Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 10, 2003, Pages 704-712

  Müller, Jakob ^a,b   Møller, Dorthe S ^a,b   Kjær, Mogens ^a,b   Nyvad, Ole ^a,b   Larsen, Niels A ^a,b   Pedersen, Erling B ^a,b  

^a HOLSTEBRO HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BACTERIAL DNA; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREVALENCE; STROKE; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY DISEASE; DIABETES MELLITUS; DNA, BACTERIAL; FEMALE; HUMANS; HYPERTENSION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 0242383168     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310016538     Document Type: Article

References (24)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbio Rev 1995; 8: 451-61.
2. Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman WP, Finley JC, Grayston JT. Confirmed previous infection with Chlamydia pneumonaie (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998; 98: 628-33.
3. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-8.
4. Kuo CC, Coulson AS, Campbell LE, Cappuccio AL, Lawrence RD, Wang SP, Grayston JT. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for aterial obstruction. J Vasc Surg 1997; 26: 29-31.
5. Kuo CC, Campbell LE. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today 1998; 10: 426-30.
6. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis - what we kow and what we do not. Review. Clin Microbiol Infect 2002; 8: 2-13.
7. Coletta A, Thackray S, Nikitin N, Cleland JG. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: Life, Danami 2, Madit-2, Miracle-ICD, Overture, Octave, Enable 1 & 2, Christmas, Affirm, Race, Wizard, AZACS, Rematch, BNP trial and Hardball. Eur J Heart Fail 2002; 4(3): 381-8.
8. Sinisalo J, Mattila K, Valtonen V, Anttonen O, Juvonen J, Melin J, et al. Effect of 3 months of antimicrobial treatment with Clarithromycin in acute non-Q-wave coronary syndrome. Circulation 2002; 105: 1555-1560.
9. Cook PJ, Lip GY, Davies P, Beevers DG, Wise R, Honeybourne D. Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 1998; 31(2): 589-94.
10. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischaemia: the West Birmingham Stroke Project. Stroke 1998; 29(2): 404-10.
11. Condos R, McClune A, Rom WN, Schluger NW. Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis. Lancet 1996; 347: 1082-5.
12. Bezold G, Volkenandt M, Gottlober P, Peter RU. Detection of herpes simplex virus and varicella-zoster virus in clinical swabs: frequent inhibition of PCR as determined by internal controls. Mol Diagn 2000; 5(4): 279-84.
13. Kubota Y. A new primer pair for detection of Chlamydia pneumoniae by polymerase chain reaction. Microbiol Immunol 1996; 40: 27-32.
14. Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000; 181 (Suppl 3): S402-10.
15. Smieja M, Mahony J, Petrich A, Boman J, Chernesky M. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis 2002; 2: 21.
16. Kaftan AH, Kaftan O. Coronary artery disease and infection with Chlamydia pneumoniae. Jpn Heart J 2000; 41(2): 165-72.
17. Leinonen M. Chlamydia pneumoniae and other risk factors for atherosclerosis. J Infect Dis 2000; 181(Suppl 3): S414-6.
18. Bauriedel G, Welsch U, Likungu JA, Welz A, Luderitz B. Chlamydia pneumoniae in coronary plaques: increased detection with acute coronary syndrome. Dtsch Med Wochenschr 1999; 124(13): 375-80.
19. Kanauchi M, Kawano T, Dohi K. Association of Chlamydia pneumoniae infection with diabetic nephropathy. Diabetes Res Clin Pract 2000; 47(1): 45-8.
20. Müller J, Nyvad O, Larsen NA, Løkkegaard N, Pedersen RS, Sølling J, Pedersen EB. Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls. Scand J Clin Lab Invest. Scand J Clin Lab Invest 2002; 62: 503-10.
21. Madre JG, Garcia JL, Gonzalez RC, Montero JM, Paniagua EB, Escribano JR, et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002; 9(3): 303-6.
22. Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischaemic stroke subtypes: results from a population-based case-control study. Stroke 2001; 32(10): 2253-8.
23. Wong YK, Dawkins KD, Ward ME. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999; 34: 1435-9.
24. Boman J, Gaydos CA. Polymerase chain reaction of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 2000; 181(Suppl. 3): 452-4.